Search…

Hao Pharmaceutical - B (02142.HK) spent HK$9.76 million on May 12 to repurchase 1.2 million shares.

12/05/2025

The Chengdu Commercial News Finance APP reported that Biopharmaceutical-B (02142.HK) announced on May 12, 2025 that the company spent 9.76 million Hong Kong dollars to repurchase 1.2 million shares, with a repurchase price of 7.96-8.58 Hong Kong dollars per share.

Latest

2 m ago

Huayi Construction (01582.HK) appointed Zhang Guanhua as executive director and chairman of the board.

3 m ago

Green City China (03900.HK): Zhou Changjiang appointed as the authorized representative to receive legal process documents.

3 m ago

The Ministry of Commerce holds a roundtable meeting for foreign trade enterprises.

4 m ago

Piper Sandler analyst Alexander Potter has maintained a "buy" rating on Tesla with a target price of $400. He believes that Tesla's fully autonomous driving is the main driver of this optimistic outlook, but also notes that the current version released four months ago still requires human intervention. The firm believes that Tesla may be quietly preparing a safer version before launching its service in Austin.

4 m ago

Piper Sandler analyst Alexander Potter maintains a "buy" rating on Tesla with a target price of $400. He believes Tesla's Fully Self-Driving (FSD) is the main driver of this optimistic outlook but also points out that the current version released four months ago still requires manual intervention. The firm believes Tesla may be quietly preparing a safer version before the launch of service in Austin.

See all latest